BMY 7378 Dihydrochloride
CAS: 21102-95-4
Ref. 3D-WAA10295
10mg | 194,00 € | ||
25mg | 310,00 € | ||
50mg | 453,00 € | ||
100mg | 739,00 € | ||
250mg | 1.160,00 € |
Información del producto
- 1,1-Cyclopentanediacetimide, N-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-, dihydrochloride
- 8-Azaspiro[4.5]decane-7,9-dione, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-, dihydrochloride
- 8-Azaspiro[4.5]decane-7,9-dione, 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-, hydrochloride (1:2)
- 8-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione hydrochloride (1:2)
- 8-[2-[4-(Methoxyphenyl)-1-Piperazinyl]Ethyl]-8-Azaspiro[4.5]Decane-7,9-Dione Dihydrochloride
- BMY 7378 dihydrochloride
- BMY7378 inhibitor
- Bmy 7378
BMY 7378 Dihydrochloride is an experimental agent that has been used in the treatment of bone cancer. It is a potent and selective antagonist for the alpha-7 nicotinic acetylcholine receptor, with low potency for the α-4β2 nicotinic acetylcholine receptor. BMY 7378 Dihydrochloride has been shown to inhibit locomotor activity and antagonize the effects of nicotine in animal studies. This drug also inhibits angiogenesis and has anti-inflammatory properties.
Propiedades químicas
Consulta técnica sobre: 3D-WAA10295 BMY 7378 Dihydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.